Unveiling the Link: Marijuana Use and Increased Risk of Peripheral Artery Disease

Photo by Budding on Unsplash

As research into the effects of marijuana continues to expand, a groundbreaking new study, presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2023 Scientific Sessions, has shed light on a concerning association between marijuana use and the risk of peripheral artery disease (PAD). Peripheral artery disease refers to the narrowing of arteries, reducing blood flow to the limbs. While marijuana has long been associated with various health benefits and risks, this study raises important questions about its impact on vascular health. In this article, we will explore the study's findings, delve into the potential mechanisms behind the link, and discuss the implications for both regular marijuana users and healthcare professionals.

Understanding Peripheral Artery Disease 

Before exploring the association with marijuana use, it's essential to grasp the basics of peripheral artery disease. PAD is a condition characterized by the narrowing of arteries, predominantly affecting the legs and sometimes the arms. It occurs due to atherosclerosis, a buildup of plaque in the arterial walls, leading to reduced blood flow.

Common risk factors for PAD include smoking, high blood pressure, high cholesterol, diabetes, and advanced age. However, recent research has unveiled a potential connection between marijuana use and an increased risk of developing this debilitating condition.

The Study: Unveiling the Association

A study conducted by the Hackensack University Medical Center in Hackensack, New Jersey, sought to explore the relationship between marijuana use and peripheral artery disease. The study examined data from a large sample of individuals, including both marijuana users and non-users, while controlling for various confounding factors. In a statement, the study's authors said that "[they] know PAD is a progressive disease that can drastically impact quality of life."

The results were concerning. The study revealed that individuals who reported regular marijuana use had a significantly higher risk of developing peripheral artery disease compared to non-users. The risk remained elevated even after adjusting for potential confounders such as smoking, age, and other known risk factors.

Possible Mechanisms: Unraveling the Connection 

To understand the association between marijuana use and peripheral artery disease, researchers hypothesize various mechanisms. One potential explanation is the impact of marijuana on blood vessels. Studies suggest that marijuana use can lead to endothelial dysfunction, affecting the lining of blood vessels and impairing their ability to dilate properly. This dysfunction may contribute to the development of atherosclerosis and subsequent peripheral artery disease.

Moreover, marijuana use is known to increase heart rate and blood pressure temporarily. This increase in cardiovascular stress could further contribute to the progression of atherosclerosis and the narrowing of arteries, exacerbating the risk of PAD.

Implications and Conclusion

The findings from this study have significant implications for both regular marijuana users and healthcare professionals. Individuals who engage in frequent marijuana use should be aware of the potential vascular risks, including the increased likelihood of peripheral artery disease. Healthcare providers should also take note of these findings and consider discussing the potential adverse effects of marijuana use with their patients, particularly those at higher risk for vascular disease.

However, it is important to note that further research is necessary to establish a definitive causal link between marijuana use and peripheral artery disease. This study serves as a critical starting point, prompting additional investigations into the mechanisms and long-term effects of marijuana on vascular health.

In conclusion, while marijuana continues to be studied for its potential therapeutic applications, this recent research highlights the need for a balanced approach to its use. It is crucial to consider both the benefits and risks associated with marijuana, particularly in relation to vascular health. As science progresses, a comprehensive understanding of these links will be essential in guiding public health policies and promoting informed decision-making regarding marijuana use.


Young P, Vadala S, Finn BC, Pankl S, Montes Onganía A, Bruetman JE. Arteriopatía periférica asociada a marihuana [Marijuana-associated peripheral arteriopathy]. Medicina (B Aires). 2019;79(2):144-146. Spanish. PMID: 31048280.

Mahtta D, Ramsey D, Krittanawong C, Al Rifai M, Khurram N, Samad Z, Jneid H, Ballantyne C, Petersen LA, Virani SS. Recreational substance use among patients with premature atherosclerotic cardiovascular disease. Heart. 2021 Apr;107(8):650-656. doi: 10.1136/heartjnl-2020-318119. Epub 2021 Feb 15. Erratum in: Heart. 2021 Nov;107(22):e16. PMID: 33589427.

Noël B, Ruf I, Panizzon RG. Cannabis arteritis. J Am Acad Dermatol. 2008 May;58(5 Suppl 1):S65-7. doi: 10.1016/j.jaad.2007.04.024. PMID: 18489050.

Katsiki N, Papadopoulou SK, Fachantidou AI, Mikhailidis DP. Smoking and vascular risk: are all forms of smoking harmful to all types of vascular disease? Public Health. 2013 May;127(5):435-41. doi: 10.1016/j.puhe.2012.12.021. Epub 2013 Feb 28. PMID: 23453194.


Dr. Mark L. Meyer Dr. Meyer graduated from Haverford College with a Bachelor of Science, High Honors, in cellular and molecular biology, Phi Beta Kappa, Magna Cum Laude. He attended the Yale University School of Medicine, where he also completed a categorical residency in Internal Medicine, served for one year as an Emergency Department attending physician, and held the title of Clinical Instructor in the Department of Surgery. During this time, Dr. Meyer obtained a J.D. from the Yale Law School, concentrating on medical ethics, scientific research law, and FDA law. He then completed a fellowship in Cardiovascular Diseases at the Hospital of the University of Pennsylvania, where he obtained Level 3 Nuclear Cardiology training.

You Might Also Enjoy...

Adobe Stock Lic. # 636822668

Binge-Drinking Can Raise CVD Risk Among Women

In recent findings presented at the American College of Cardiology’s Annual Scientific Session, a new study has cast light on the relationship between alcohol consumption and coronary heart disease (CHD) among young to middle-aged women.
AdobeStock Lic. # 224621165

Statins May Lower Dementia Risk in People With Heart Failure

Statins, widely known for their cholesterol-lowering effects, have been the cornerstone of cardiovascular disease prevention for decades. However, recent research published on January 16, 2024, in Lancet Regional Health by researchers in Hong Kong.